Tag: Research Capacity Building

Posted on

Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar

by
0 comments

UPDATE: The webinar slides [PDF] and video are now available.

I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 2 funding opportunity announcement (FOA) (PAR-23-063) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to strengthen successful Phase 1 centers through further research infrastructure improvements and continued development of investigators with shared scientific interests who can compete effectively for independent research funding.

Application receipt date: May 29, 2023
Earliest start date: April 2024

Continue reading “Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar”
Posted on

COBRE Phase 1 Funding Opportunities for Data Sciences and Women’s Health Research and Upcoming Webinar

by
0 comments

UPDATE: The webinar slides [PDF] and video are now available.

We’re pleased to announce that we’ve published two notices of special interest (NOSIs) requesting applications to PAR-22-250, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), to build research capacity in data sciences (NOT-GM-23-011) and women’s health (NOT-GM-23-012) in IDeA states.

These NOSIs highlight the Office of Data Science Strategy’s interest in supporting meritorious applications on data science relevant to biomedical research, and the Office of Research on Women’s Health’s interest in supporting a meritorious application on women’s health.

Continue reading “COBRE Phase 1 Funding Opportunities for Data Sciences and Women’s Health Research and Upcoming Webinar”
Posted on

Centers of Biomedical Research Excellence (COBRE) Phase 1 Funding Opportunity and Upcoming Webinar

by
0 comments

UPDATE: The slides [PDF] and video from this webinar are now available.

I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 1 funding opportunity announcement (FOA) (PAR-22-250) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to establish a center of excellence that helps develop a critical mass of investigators and improve infrastructure in an area of biomedical research.

Application receipt date: January 30, 2023
Earliest start date: December 2023

Continue reading “Centers of Biomedical Research Excellence (COBRE) Phase 1 Funding Opportunity and Upcoming Webinar”
Posted on

Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar

by
0 comments

UPDATE: The slides [PDF] and video for this webinar are now available.

I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 2 funding opportunity announcement (FOA) (PAR-22-163) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to strengthen successful Phase 1 centers through further research infrastructure improvements and continued development of investigators with shared scientific interests who can compete effectively for independent research funding.

Continue reading “Centers of Biomedical Research Excellence (COBRE) Phase 2 Funding Opportunity and Upcoming Webinar”
Posted on

Webinar for COBRE Program Applicants and Grantees

by
2 comments

UPDATE: The video and slides [PDF] from this webinar are now available.

If you’re planning to apply for a Phase 1, 2, or 3 Centers of Biomedical Research Excellence (COBRE) grant, it’s important that you attend our upcoming webinar:

Wednesday, October 27, 3:00-4:30 p.m. ET

During the webinar, we’ll present an overview of the COBRE program’s objectives, eligibility and reporting requirements, and other key aspects of the funding opportunity announcements. We’ll also answer any questions that you have.

Continue reading “Webinar for COBRE Program Applicants and Grantees”
Posted on

Funding Opportunities: COBRE Phase 1 Applications for Women’s Health and Data Sciences Research

by , , and
0 comments

We’re pleased to announce that we’ve published two notices of special interest (NOSI) calling for applications to PAR-19-313, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), that focus on research on women’s health (NOT-GM-21-056) and data sciences (NOT-GM-21-062).

These NOSIs highlight the Office of Research on Women’s Health’s interest in supporting a meritorious application on women’s health, and the Office of Data Science Strategy’s interest in supporting a meritorious application on data science relevant to biomedical research. Applications for these NOSIs must be submitted in response to and meet all eligibility criteria of PAR-19-313.

Continue reading “Funding Opportunities: COBRE Phase 1 Applications for Women’s Health and Data Sciences Research”
Posted on

Funding Opportunity: Urgent Competitive Revisions to IDeA-CTR Awards to Address the Continuing Need for Documenting COVID-19-Related Patient Outcomes

by and
0 comments

We’re pleased to announce a new notice of special interest (NOSI) (NOT-GM-21-050) to address the urgent need for documenting COVID-19-related outcomes of patients, including those suffering from health disparities, which helps foster COVID-19-related clinical research. Competitive revisions to active IDeA-CTR (U54) awards will be considered for the purpose of sustaining and strengthening the IDeA state COVID-19 patient registry, a component of the National COVID Cohort Collaborative.

Applications are due by June 18, 2021. If you have any questions about this NOSI, please contact Hongwei Gao.

Posted on

Funding Opportunities: Urgent Competitive Revisions to NIGMS IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy

by
0 comments

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards to support vaccine hesitancy research relevant to SARS-CoV-2. The supplements are aimed at studying the causes of SARS-CoV-2 vaccine hesitancy in IDeA states and/or American Indian/Alaska Native communities, and at developing innovative evidence-based interventions to enhance vaccine acceptance with the goal of increased vaccine uptake.

Applications are due by April 30, 2021; see NOT-GM-21-021 for additional details.

If you have any questions about this supplement opportunity, please contact me.

Posted on

Funding Opportunities: Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies

by
0 comments

UPDATE: The slides [PDF] and video from this webinar are now available.

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards for sequencing-based surveillance studies of the SARS-CoV-2 virus to track variants circulating in communities the IDeA and NARCH programs serve. The supplements will support SARS-CoV-2 viral genome sequencing and analysis studies. Projects are expected to expand on or collaborate with ongoing SARS-CoV-2 testing studies or programs in order to leverage resources and deliver results quickly to help address the urgent challenge.

Applications are due by March 31, 2021; see NOT-GM-21-031 for additional details.

If you have any questions about this supplement opportunity, please contact me.